Small Stocks, Big Money™

Unusual Machines (NYSE American: UMAC), a drone and drone components manufacturer, announced it formalized its contract for Allan Evans to continue to serve as CEO following Unusual Machine’s Board of Directors unanimous approval. The two-year contract follows a rapid series of business developments since Dr. Evans became the CEO less than six months ago. Since his initial appointment, Unusual Machines successfully listed on the NYSE American, acquired Rotor Riot and Fat Shark from Red Cat Holdings, reincorporated in Nevada, and joined the Red Cat Futures Initiative as part of the Company’s expansion into the U.S. government segment of the market.

Can-Fite BioPharma (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance for Namodenoson for the treatment of patients with metabolic dysfunction-associated steatohepatitis (MASH), also known as non-alcoholic steatohepatitis (NASH), for the Company’s ongoing Phase IIb clinical study.

Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, reported consolidated financial results for the first quarter ended March 31, 2024. "During the first quarter, we built on the momentum generated during 2023," commented Zomedica Chief Executive Officer, Larry Heaton. "As we continued to execute on our strategy to drive growth in 2024 and beyond, we delivered the strongest first quarter in company history. Looking ahead, we remain enthusiastic about the opportunity that exists for Zomedica. With our strategy in place to accelerate growth, maintain industry-leading margins, and capture efficiencies, we are very well positioned to scale the business to achieve profitability and grow revenue to $100 million and beyond.”

LOBO EV Technologies (Nasdaq: LOBO), an innovative electric vehicle manufacturer and seller, announced its financial results for the fiscal year ended December 31, 2023. “With the successful capital influx from our March 2024 IPO, we are rapidly scaling our operations,” stated Huajian Xu, CEO of LOBO. “We’ve added over ten new dealer customers to our network this year, securing potential orders worth more than $5 million, with over $1 million in new paid deposits already received. To meet this surging demand, we’ve recently further expanded our production capabilities with the addition of two high-capacity assembly lines that will enter production at our new Wuxi facility in early May. The new assembly lines will enable us to add new in-demand products to our portfolio, and together with production improvements at our other assembly lines, our overall production capacity will be up nearly 20% in 2024.”